Skip to content
← Holders

B Group, Inc.

What B Group, Inc. reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 2043476 · Filed Nov 16, 2026

Positions
19
Reported value
$162.1M
Opened
1
Closed
1
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$135.9M
    20 positions
  2. Dec 31, 2025$135.4M
    16 positions
  3. Mar 31, 2026$134.9M
    20 positions
  4. Jun 30, 2026$213M
    19 positions
  5. Sep 30, 2026$162.1M
    19 positions
SecuritySharesChangeValueOf portfolio
ADMAAdma Biologics, Inc.
3.3M±0%$32.7M20.2%
FTHFaeth Therapeutics, Inc.
610.2K±0%$18.1M11.2%
PALIPalisade Bio, Inc.
11.4M±0%$15.4M9.5%
NRXPNRX Pharmaceuticals, Inc.
4.3M+4.5%$12.5M7.7%
ZLABZai Lab Ltd
450.6K±0%$11.9M7.3%
PRAXPraxis Precision Medicines, Inc.
33.2K±0%$9.7M6%
SGHTSight Sciences, Inc.
970K±0%$9.1M5.6%
TSHATaysha Gene Therapies, Inc.
1.8M±0%$8.8M5.4%
IOVAIovance Biotherapeutics, Inc.
425K−71.7%$6.3M3.9%
GPCRStructure Therapeutics Inc.
180K+28.6%$5.6M3.5%
SYRESpyre Therapeutics, Inc.
62.5K−10.7%$5.6M3.4%
CLLSCellectis S.A.
3.3M±0%$5M3.1%
AURAAura Biosciences, Inc.
764.2K±0%$4.8M3%
DRUGBright Minds Biosciences Inc.
95K+40.7%$4.7M2.9%
ORKAOruka Therapeutics, Inc.
55K−26.7%$4.6M2.8%
ASMBAssembly Biosciences, Inc.
175.7K±0%$4.1M2.5%
RAREUltragenyx Pharmaceutical Inc.
135K±0%$2M1.3%
FHTXFoghorn Therapeutics Inc.
200K±0%$714K0.4%
QTTBQ32 Bio Inc.
65KNew$537.6K0.3%